Vehicles for genetic vaccines against human immunodeficiency virus: induction of T cell-mediated immune responses.

Vehicles for genetic vaccines against human immunodeficiency virus: induction of T cell-mediated immune responses.

Success of a candidate vaccine against human immunodeficiency virus (HIV) depends on the type, site, strength, longevity and specificity of the immune responses it induces. The specificity of a vaccine is determined by the HIV-derived immunogens it employs in its formulation. Central to the other fe...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखक:	Hanke, T
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	2001

समान संसाधन

DNA vaccines against human immunodeficiency virus type 1.
द्वारा: Estcourt, M, और अन्य
प्रकाशित: (2004)

Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine.
द्वारा: Nixon, D, और अन्य
प्रकाशित: (2000)

Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction.
द्वारा: Hanke, T, और अन्य
प्रकाशित: (2007)

Booster vaccination against SARS-CoV-2 induces potent immune responses in people with human immunodeficiency virus
द्वारा: Fidler, S, और अन्य
प्रकाशित: (2022)

Induction of human immunodeficiency virus type 1-specific T cells by a bluetongue virus tubule-vectored vaccine prime-recombinant modified virus Ankara boost regimen.
द्वारा: Larke, N, और अन्य
प्रकाशित: (2005)

Enhanced immunogenicity using an alphavirus replicon DNA vaccine against human immunodeficiency virus type 1.
द्वारा: Nordström, E, और अन्य
प्रकाशित: (2005)

Induction of human immunodeficiency virus (HIV-1) envelope specific cell-mediated immunity by a non-homologous synthetic peptide.
द्वारा: Ammar Achour, और अन्य
प्रकाशित: (2007-11-01)

A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques.
द्वारा: Wee, E, और अन्य
प्रकाशित: (2002)

Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design.
द्वारा: Parren, P, और अन्य
प्रकाशित: (1997)

MODELING THE CYTOTOXIC IMMUNE RESPONSE EFFECTS ON HUMAN IMMUNODEFICIENCY VIRUS
द्वारा: Jeimy Lorena Pérez Ibarra, और अन्य
प्रकाशित: (2014-12-01)

Specific proliferative T cell responses and antibodies elicited by vaccination with simian immunodeficiency virus Nef do not confer protection against virus challenge.
द्वारा: Wade-Evans, A, और अन्य
प्रकाशित: (2001)

Evaluation of response to hepatitis B virus vaccine in adults with human immunodeficiency virus
द्वारा: Arlete F. Rech-Medeiros, और अन्य
प्रकाशित: (2019-09-01)

Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity.
द्वारा: Sharpe, S, और अन्य
प्रकाशित: (2001)

Emerging Targets for Developing T Cell-Mediated Vaccines for Human Immunodeficiency Virus (HIV)-1
द्वारा: Danushka K. Wijesundara, और अन्य
प्रकाशित: (2017-10-01)

Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design".
द्वारा: Parren, P, और अन्य
प्रकाशित: (1997)

Nucleocapsid-like particles, an alternative and safe vaccine strategy against Dengue virus based on the induction of cell-mediated alone adaptive immune responses
द्वारा: Lázaro Gil, और अन्य
प्रकाशित: (2018-03-01)

The immune response to human immunodeficiency virus type 1 (HIV-1)
द्वारा: Turnbull, E, और अन्य
प्रकाशित: (2005)

Immunity to Human Immunodeficiency Virus (HIV) Infection
द्वारा: Carlo Torti, और अन्य
प्रकाशित: (2012-01-01)

Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes.
द्वारा: Reyes-Sandoval, A, और अन्य
प्रकाशित: (2004)

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge
द्वारा: Todd Bradley, और अन्य
प्रकाशित: (2017-06-01)

Antiretroviral agents against human immunodeficiency virus
द्वारा: Ingrid Barcelos de Oliveira, और अन्य
प्रकाशित: (2022-01-01)

Development of vaccines against gonorrhoea, syphilis, chlamydia, herpes simplex virus, human immunodeficiency virus and Zika virus
द्वारा: McIntosh D.
प्रकाशित: (2019-12-01)

Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses.
द्वारा: Lauer, G, और अन्य
प्रकाशित: (2002)

Erratum: Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction (Journal of General Virology (2007) vol. 88 ( 1) (1-12))
द्वारा: Hanke, T, और अन्य
प्रकाशित: (2008)

Replication-deficient recombinant adenoviruses expressing the human immunodeficiency virus Env antigen can induce both humoral and CTL immune responses in mice.
द्वारा: Bruce, C, और अन्य
प्रकाशित: (1999)

Escape of human immunodeficiency virus from immune control.
द्वारा: McMichael, A, और अन्य
प्रकाशित: (1997)

Immunization of children at risk of infection with human immunodeficiency virus
द्वारा: Moss William J., और अन्य
प्रकाशित: (2003-01-01)

Genetic diversity of human immunodeficiency viruses and antiretroviral therapy
द्वारा: M R Bobkova
प्रकाशित: (2016-11-01)

The Effect of Human Immunodeficiency Virus and Cytomegalovirus Infection on Infant Responses to Vaccines: A Review
द्वारा: Olivia Falconer, और अन्य
प्रकाशित: (2018-03-01)

Antibody Responses to Trivalent Influenza Vaccine in Iranian Adults Infected with Human Immunodeficiency Virus
द्वारा: Mehrnaz Rasoolinejad, और अन्य
प्रकाशित: (2013-03-01)

Antibody Responses to Trivalent Influenza Vaccine in Iranian Adults Infected with Human Immunodeficiency Virus
द्वारा: Mehrnaz Rasoolinejad, और अन्य
प्रकाशित: (2013-03-01)

Induction of Autophagy to Achieve a Human Immunodeficiency Virus Type 1 Cure
द्वारा: Grant R. Campbell, और अन्य
प्रकाशित: (2021-07-01)

Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus
द्वारा: Beltrán LM, और अन्य
प्रकाशित: (2015-01-01)

Immunogenicity and Efficacy of Vaccination in People Living with Human Immunodeficiency Virus
द्वारा: Eeva Tortellini, और अन्य
प्रकाशित: (2023-08-01)

Impact of age and pre-existing immunity on the induction of human antibody responses against influenza B viruses
द्वारा: Michael A. Carlock, और अन्य
प्रकाशित: (2019-09-01)

Induction of Neutralizing Responses against Autologous Virus in Maternal HIV Vaccine Trials
द्वारा: Eliza D. Hompe, और अन्य
प्रकाशित: (2020-06-01)

A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans.
द्वारा: Mwau, M, और अन्य
प्रकाशित: (2004)

Vaccine platform for prevention of tuberculosis and mother-to-child transmission of human immunodeficiency virus type 1 through breastfeeding.
द्वारा: Im, E, और अन्य
प्रकाशित: (2007)

Human Immunodeficiency Virus
द्वारा: Gupta, R, और अन्य
प्रकाशित: (2009)

Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design (vol 57, pg 105, 1997)
द्वारा: Parren, P, और अन्य
प्रकाशित: (1997)